GH Research plc
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From GH Research plc
Public Company Edition: Almost halfway through the year, initial public offerings equal nearly three-quarters of the 2020 total. Also, Pardes is one of four new SPAC mergers; HUTCHMED launched an IPO in Hong Kong; and Zentalis, Theravance and BioXcel launched follow-on offerings.
Public Company Edition: Eight drug developers launched initial public offerings in the US that grossed $1.46bn combined during the week of 14 to 18 June as biotechnology stock values increased. Also, C4 Therapeutics led recent follow-on offerings, raising $180.8m.
- Other Names / Subsidiaries
- GH Research Limited
- GH Research Ireland Ltd.